Home » ALINEA PHARMA GETS $45M
ALINEA PHARMA GETS $45M
MPM Capital Ventures said Tuesday it has invested $45 million in Alinea Pharmaceuticals, a biotech firm working on methods for treating complications associated with diabetes. Todd Foley, a partner at MPM who led the search for a suitable investment, said Alinea is working on a treatment for diabetic neuropathy-a form of nerve damage that afflicts a large number of diabetic patients. The clinical-stage startup is also working on a program that would improve how diabetics manage their blood sugar.
Red Herring (http://www.redherring.com/Article.aspx?a=13954&hed=Alinea%2BPharma%2BGets%2B%2445M)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May